Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2025-12-29 @ 9:17 PM
Study NCT ID:
NCT01825603
Status:
COMPLETED
Last Update Posted:
2023-12-28
First Post:
2013-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
Sponsor:
University of Nebraska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-27
First Submit QC Date:
None
Study First Post Date:
2013-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-21
Last Update Post Date:
2023-12-28
Last Update Post Date Type:
ACTUAL